Average Co-Inventor Count = 6.13
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ariad Pharmaceuticals, Inc. (33 from 69 patents)
2. Ariad Gene Therapeutics, Inc. (2 from 13 patents)
3. Araid Gene Therapeutics, Inc. (1 from 1 patent)
4. Dalgarno, David C. (0 patent)
5. Zhu, Xiaotian (0 patent)
6. Wang, Yihan (0 patent)
7. Huang, Wei-sheng (0 patent)
8. Shakespeare, William C. (0 patent)
36 patents:
1. 11753404 - Aminothiazole compounds as c-Kit inhibitors
2. 11117883 - Benzimidazole compounds as c-Kit inhibitors
3. 11001580 - Aminothiazole compounds as c-Kit inhibitors
4. 9834521 - Choline kinase inhibitors
5. 9834518 - Compounds for inhibiting cell proliferation in EGFR-driven cancers
6. 9834571 - Compounds for inhibiting cell proliferation in EGFR-driven cancers
7. 9573934 - Methods and compositions for the synthesis of multimerizing agents
8. 9278971 - Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors
9. 9273077 - Phosphorus derivatives as kinase inhibitors
10. 9090561 - Acetylenic heteroaryl compounds
11. 9029533 - Substituted acetylenic imidazo[1,2-A]pyridazines as kinase inhibitors
12. 9024028 - Methods and compositions for the synthesis of multimerizing agents
13. 9024014 - Phosphorus-containing compounds and uses thereof
14. 9012462 - Phosphorous derivatives as kinase inhibitors
15. 8912330 - Azaindole derivatives as kinase inhibitors